Kimberlee C Drapkin, Director at LENZ Therapeutics, holds ― shares in LENZ Therapeutics (Ticker: LENZ), holds ― shares in Climb Bio (Ticker: CLYM), holds 48.30K shares in Acumen Pharmaceuticals (Ticker: ABOS). Most recently, Kimberlee C Drapkin ― shares of LENZ Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Kimberlee C Drapkin?
The percentage of profitable transactions made by Kimberlee C Drapkin is 60%.
What is the average return per transaction made by Kimberlee C Drapkin?
The average return per transaction made by Kimberlee C Drapkin is 11.50%.
What stocks does Kimberlee C Drapkin hold?
Kimberlee C Drapkin holds: LENZ, CLYM, JNCE, KANT, ABOS stocks.
What was Kimberlee C Drapkin’s latest transaction?
Kimberlee C Drapkin latest transaction was an Uninformative Buy of ―.
What was Kimberlee C Drapkin's most profitable transaction?
Kimberlee C Drapkin’s most profitable transaction was an Informative Sell of JNCE stock on January 11, 2022. The return on the trade was 80.90%.
What is Kimberlee C Drapkin's role in LENZ Therapeutics?
Kimberlee C Drapkin's role in LENZ Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.